Trial Design Solutions
-
Accelerating Patient Engagement And Recruitment
11/20/2023
Explore this suite of multichannel, patient-centered solutions that are powering rapid clinical trial education, engagement, and enrollment.
-
Enable Greater Diversity In Clinical Trials
10/19/2023
Discover how to seamlessly integrate a broad range of leading industry solutions to create an innovative, patient-centered approach that caters to specific diversity and clinical trial requirements.
-
Optimize Your Research Site's Growth And Financial Success
10/25/2022
Explore how Elligo enhances the site financial process through streamlined, automated, cost-effective solutions.
-
Your Global CRO Partner In Oncology And Hematology
1/14/2025
Learn about an organization dedicated to providing personalized and adaptive trial solutions and managing complex oncology and hematology clinical trials.
-
Bringing Endocrine And Metabolic Disease Treatments To Market
9/20/2023
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy.
-
Biorasi Rare and Urgent Disease
9/21/2021
Read how Biorasi's speed and agility make all the difference in overcoming unique obstacles to rare disease clinical trials.
-
Early Phase Trials In Australia
9/6/2024
Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.
-
How To Avoid Costly Study Delays And Mitigate Risks
7/22/2024
Are you still in doubt about your study protocol or how to determine the sample size? Gain access to free clinical trial budgeting and MedSci consulting services from a leading Eastern European CRO.
-
Elligo's Customizable Solutions For Sponsors
1/17/2023
With the personalized PatientSelect® and SiteSelect service models and proprietary technology, trials are better equipped to research diagnostics, drugs, biologics, and devices at every phase.
-
Rave RTSM: Direct-To-Patient
10/3/2022
As the healthcare industry continues to deepen its focus on virtual trials and patient-centricity, the popularity of Direct-to-Patient (DtP) services in the clinical trial setting has grown significantly. Rave RTSM DtP (Randomization and Trial Supply Management Direct to Patient) brings investigational medicinal products (IMP) directly to a patient’s home, bypassing the need for the patient to travel directly to a site.